Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 27 June 2023, 13:00 HKT/SGT
Share:
    

Source: DC Healthcare
DC Healthcare to Raise RM49.81 Million from IPO
Group plans to open clinics in northern region of Peninsular Malaysia while expanding presence in southern region

KUALA LUMPUR, June 27, 2023 - (JCN Newswire) - DC Healthcare Holdings Berhad, an established aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, launched the prospectus today in conjunction with the Group's initial public offering (IPO) on the ACE Market of Bursa Malaysia Securities Berhad.

DR. CHONG TZE SHENG, Managing Director; DATUK BILL TAN, Managing Director of Corporate Finance,
M&A Securities Sdn Bhd [L-R]


The IPO will raise RM49.81 million via the issuance of 199.26 million new shares at the IPO price of RM0.25 per share to fund DC Healthcare's growth plans as well as working capital and repayment of borrowings. The proceeds will be used in the following manner:

- RM9.44 million to establish aesthetic medical clinics
- RM13.12 million to purchase medical machinery and equipment
- RM6.24 million to repay borrowings
- RM17.01 million for working capital, including staff salaries as well as medical supplies and consumables
- RM4.00 million for estimated listing expenses

Managing Director of DC Healthcare, Dr. Chong Tze Sheng said, "DC Healthcare's expansion plan is based on demand for aesthetic medical services as people are becoming more aware on skin health, as well as wanting to look and feel good about themselves, especially in the long run. It is projected that aesthetic medical services and general medical services related to skin disease will increase due to people having more disposable income for discretionary spending and becoming better educated on skin conditions."

Mr. Danny Wong, Deputy Head of Corporate Finance, of M&A Securities Sdn Bhd said, "The Malaysian market for aesthetic medical services will continue to grow supported by demand as incomes rise and populations aged. This will be helped along by the increased consumerism and growing influence of social media removing the stigma of aesthetic medical procedures. With the growing acceptance of such treatments, the domestic aesthetic medical services market is projected to have a compound annual growth rate of 18.8% from 2021 to 2027 valuing the total market at RM1.03 billion."

DC Healthcare - or famously known 'Dr. Chong Clinic' or 'Klinik Dr. Chong' - provides aesthetic services, general medical services and sale of skincare products. DC Healthcare currently has 13 clinics and 10 LCP Certified Aesthetic Physicians, assisted by 29 resident medical doctors in the central and southern regions of Peninsular Malaysia namely in Negeri Sembilan, Selangor, Johor, and Kuala Lumpur.

For the financial year ended 31 December 2022 (FYE2022), the Group recorded revenue of RM51.96 million compared with RM25.48 million in FYE2021 with a net profit margin of 18.40% and 18.06% respectively.

Aesthetic services contributed 89.96% to total revenue for FYE2022 and 84.88% in FYE2021, compared to general medical services who contributed 10.04% in FYE2022 and 15.12% in FYE2021.

In addition, for the financial year ended 31 December 2020 (FYE2020) and 31 December 2019 (FYE2019), DC Healthcare registered revenue RM14.45 million and RM12.21 million respectively. Aesthetic services contributed 89.80% in FYE2019 and 87.50% in FYE2020 to the total revenue, while general medical services contributed 10.20% in FYE2019 and 12.50% in FYE2020.

DC Healthcare Holdings Berhad: http://dchealthcareholdings.com/

Image 1
DR. CHONG TZE SHENG, Managing Director; DATUK BILL TAN, Managing Director of Corporate Finance, M&A Securities Sdn Bhd [L-R]
( https://photos.acnnewswire.com/tr:n-650/2023627.DCHealthcare1.jpg )

Image 2
1. Mr. Lee Yoke Wah, Associate Director of Corporate Finance, M&A Securities Sdn Bhd
2. Ms. Sim Lee San, Independent Non-Executive Director, DC Healthcare Holdings Berhad
3. Ms. Rekha A/P Palanysamy, Independent Non-Executive Director, DC Healthcare Holdings Berhad
4. Datuk Dr Mohd Noor Bin Awang, Independent Non-Executive Chairman, DC Healthcare Holdings Berhad
5. Dr. Chong Tze Sheng, Managing Director, DC Healthcare Holdings Berhad
6. Datuk Bill Tan, Managing Director of Corporate Finance, M&A Securities Sdn Bhd
7. Dr. Lai Ngan Chee, Executive Director, DC Healthcare Holdings Berhad
8. Ms. Yap Ee Ling, Independent Non-Executive Director, DC Healthcare Holdings Berhad
9. Mr. Danny Wong, Deputy Head of Corporate Finance, M&A Securities Sdn Bhd [L-R]
( https://photos.acnnewswire.com/tr:n-650/2023627.DCHealthcare2.jpg )


Topic: IPO
Source: DC Healthcare

Sectors: BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



DC Healthcare
June 13, 2024 15:00 HKT/SGT
DC Healthcare's Approve All Resolutions in AGM
Apr 18, 2024 19:33 HKT/SGT
DC Healthcare Rides the Wave of Success with New Openings at Publika and Bukit Indah
Mar 25, 2024 19:00 HKT/SGT
DC Healthcare Continues Growth Momentum with Second DC Body Outlet Opening in USJ Taipan
Feb 29, 2024 11:20 HKT/SGT
DC Healthcare Further Expands into Perai, Pulau Pinang with Two New Outlets, and Introduces DC Body
Feb 21, 2024 20:00 HKT/SGT
DC Healthcare Announces Expansion with New Branches in Johor Bahru and Ipoh
Nov 1, 2023 19:00 HKT/SGT
DC Healthcare Unveils Innovative Skincare Range 'newB' Under Subsidiary Ten Doctors Sdn Bhd
July 17, 2023 11:00 HKT/SGT
DC Healthcare Debuts on ACE Market with a Premium of RM0.15 over IPO Price
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: